Histoepigenetic analysis of the mesothelin network within pancreatic ductal adenocarcinoma cells reveals regulation of retinoic acid receptor gamma and AKT by mesothelin

被引:0
作者
Eugene Lurie
Dongliang Liu
Emily L. LaPlante
Lillian R. Thistlethwaite
Qizhi Yao
Aleksandar Milosavljevic
机构
[1] Baylor College of Medicine,Department of Molecular and Human Genetics
[2] Baylor College of Medicine,Michael E. DeBakey Department of Surgery
[3] Baylor College of Medicine,Program in Quantitative and Computational Biosciences
[4] Michael E. DeBakey VA Medical Center,Center for Translational Research on Inflammatory Diseases (CTRID)
[5] The University of Texas M. D. Anderson Cancer Center,Department of Translational Molecular Pathology
来源
Oncogenesis | / 9卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
To enable computational analysis of regulatory networks within the cancer cell in its natural tumor microenvironment, we develop a two-stage histoepigenetic analysis method. The first stage involves iterative computational deconvolution to estimate sample-specific cancer-cell intrinsic expression of a gene of interest. The second stage places the gene within a network module. We validate the method in simulation experiments, show improved performance relative to differential expression analysis from bulk samples, and apply it to illuminate the role of the mesothelin (MSLN) network in pancreatic ductal adenocarcinoma (PDAC). The network analysis and subsequent experimental validation in a panel of PDAC cell lines suggests AKT activation by MSLN through two known activators, retinoic acid receptor gamma (RARG) and tyrosine kinase non receptor 2 (TNK2). Taken together, these results demonstrate the potential of histoepigenetic analysis to reveal cancer-cell specific molecular interactions directly from patient tumor profiles.
引用
收藏
相关论文
共 95 条
[1]  
Frierson HF(2003)Large-scale molecular and tissue microarray analysis of mesothelin expression in common human carcinomas Hum. Pathol. 34 605-609
[2]  
Nahm CB(2019)Biomarker panel predicts survival after resection in pancreatic ductal adenocarcinoma: a multi-institutional cohort study Eur. J. Surg. Oncol. 45 218-224
[3]  
Bharadwaj U(2008)Mesothelin-induced pancreatic cancer cell proliferation involves alteration of cyclin E via activation of signal transducer and activator of transcription protein 3 Mol. Cancer Res 6 1755-1765
[4]  
Li M(2011)Mesothelin overexpression promotes autocrine IL-6/sIL-6R trans-signaling to stimulate pancreatic cancer cell proliferation Carcinogenesis 32 1013-1024
[5]  
Chen C(2011)Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression Mol. Cancer 10 110-124
[6]  
Yao Q(2016)MUC16 contributes to the metastasis of pancreatic ductal adenocarcinoma through focal adhesion mediated signaling mechanism Genes Cancer 7 926-931
[7]  
Bharadwaj U(2013)Mesothelin binding to CA125/MUC16 promotes pancreatic cancer cell motility and invasion via MMP-7 activation Sci. Rep. 3 31-40
[8]  
Marin-Muller C(2017)Efficient growth suppression in pancreatic cancer PDX model by fully human anti-mesothelin CAR-T cells Protein Cell 8 858-868
[9]  
Li M(2018)Engineered CAR T cells targeting mesothelin by piggyBac transposon system for the treatment of pancreatic cancer Cell Immunol. 329 29-32
[10]  
Chen C(2012)A live-attenuated Listeria vaccine (ANZ-100) and a live-attenuated Listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: phase I studies of safety and immune induction Clin. Cancer Res. 18 439-447